TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26745715

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (CBT) intervention for weight loss
Number of subjects: 119
Study: 24948508

Group type: EXPERIMENTAL
Intervention: Hydrogel coils
Number of subjects: 447

Group type: COMPARATOR
Intervention: Platinum coils
Number of subjects: 447
Study: 23054164

Group type: EXPERIMENTAL
Intervention: Greater concern about exposure to occupational hazards
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive view of their unions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older age, higher levels of educational attainment and household income, fewer cigarettes smoked per day
Number of subjects: 0
Study: 20336537

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open surgery (CO)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 19024521

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 7 days
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (surgical resection alone)
Number of subjects: 59
Study: 16244520

Group type: EXPERIMENTAL
Intervention: Intramuscular electrical stimulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cuff-type sling (Control)
Number of subjects: 61
Study: 11124750

Group type: EXPERIMENTAL
Intervention: Mebendazole (administered every 2 months for 8 months and again at 12 months)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo tablets (administered every 2 months for 8 months and again at 12 months)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 123
Study: 9272808

Group type: EXPERIMENTAL
Intervention: Patients with a history of injection drug use (IDU)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Patients without a history of injection drug use (non-IDU)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Patients acknowledging continued drug use
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Patients denying any recent drug use
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Patients participating in a methadone maintenance program
Number of subjects: 516
Study: 7878558

Group type: EXPERIMENTAL
Intervention: 2.0 mg terbutaline from a pressurised metered dose inhaler (MDI) with spacer (4 x 0.25 mg doses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1.0 mg terbutaline from a Turbohaler (2 x 0.5 mg doses)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo from a pressurised metered dose inhaler (MDI)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo from a Turbohaler
Number of subjects: 15
Study: 2975458

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (2 pmol/kg/minute for two hours) in sodium-replete normal subjects
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Incremental doses of synthetic atrial natriuretic peptide in sodium-replete dogs
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Incremental doses of synthetic atrial natriuretic peptide in sodium-depleted dogs
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (10 pmol/kg/minute for one hour) in patients with end-stage renal failure
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo in sodium-replete normal subjects
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo in sodium-replete dogs
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo in sodium-depleted dogs
Number of subjects: 200
Study: 30403576

Group type: EXPERIMENTAL
Intervention: CGM+CSII
Number of subjects: 75

Group type: COMPARATOR
Intervention: CGM+MDI (control)
Number of subjects: 75
Study: 27418254

Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study: 24535888

Group type: EXPERIMENTAL
Intervention: Fexinidazole single dose (100 to 3,600 mg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fexinidazole multiple ascending doses (up to 3,600 mg/day for 14 days)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fexinidazole loading dose of 1,800 mg/day for 4 days followed by 1,200 mg/day for 6 days with a normal meal
Number of subjects: 154

Group type: COMPARATOR
Intervention: Fexinidazole tablet formulation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fexinidazole with food intake
Number of subjects: 154

Group type: COMPARATOR
Intervention: Fexinidazole with low-fat regimen
Number of subjects: 154
Study: 22872689

Group type: EXPERIMENTAL
Intervention: Tight glucose control (TGC)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study: 20679638

Group type: EXPERIMENTAL
Intervention: Atomoxetine (target dosage = 80 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 17287629

Group type: EXPERIMENTAL
Intervention: Early compression stockings (immediately after diagnosis)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (compression stockings started 2 weeks after diagnosis)
Number of subjects: 73
Study: 16095471

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioural Therapy (CBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Group Psychoeducation (PE)
Number of subjects: 88
Study: 12229974

Group type: EXPERIMENTAL
Intervention: 900 mg/day UDCA
Number of subjects: 15
Study: 9523249

Group type: EXPERIMENTAL
Intervention: styrene exposure
Number of subjects: 25
Study: 7661476

Group type: EXPERIMENTAL
Intervention: General anesthesia and postoperative patient-controlled intravenous narcotic analgesia (GEN)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Epidural anesthesia and postoperative continuous epidural analgesia (EPI)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: General anesthesia (GEN)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Epidural anesthesia (EPI)
Number of subjects: 78
Study: 2547680

Group type: EXPERIMENTAL
Intervention: Enalapril, 0.5 mg.kg‐1.day‐1 for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 18
Study: 1095108

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of Solcoseryl
Number of subjects: 57
Study: 30599063

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 117

Group type: COMPARATOR
Intervention: Dabigatran
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 117
Study: 29361939

Group type: EXPERIMENTAL
Intervention: Artemisinin-based combination therapy
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Chloroquine with primaquine (7-9 days: total dose 3-4.2 mg/kg)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Another artemisinin-based combination therapy
Number of subjects: 264
Study: 26184830

Group type: EXPERIMENTAL
Intervention: Chorion membrane placement at test sites during periodontal flap surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control sites (no chorion membrane) during periodontal flap surgery
Number of subjects: 0
Study: 24877997

Group type: EXPERIMENTAL
Intervention: Celgosivir (initial 400 mg loading dose within 6 h of randomisation, followed by 200 mg every 12 h for a total of nine doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Celgosivir
Number of subjects: 50
Study: 22270489

Group type: EXPERIMENTAL
Intervention: Two-leg passive cycling at 60 RPM
Number of subjects: 11

Group type: COMPARATOR
Intervention: One-leg passive cycling at 60 RPM
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Two-leg passive cycling at 90 RPM
Number of subjects: 11

Group type: COMPARATOR
Intervention: One-leg passive cycling at 90 RPM
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Repeated trials of passive cycling
Number of subjects: 11
Study: 19508318

Group type: EXPERIMENTAL
Intervention: Home-based programme consisting of 40 weekly visits
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no additional home-based programme)
Number of subjects: 59
Study: 17489029

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15130862

Group type: EXPERIMENTAL
Intervention: University-based (UB) group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Home-based (HB) group
Number of subjects: 40
Study: 11906418

Group type: EXPERIMENTAL
Intervention: Intraoperative bupivacaine infiltration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (non-infiltrated groin)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Infiltrated groin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pre-incision infiltration
Number of subjects: 18
Study: 10023943

Group type: EXPERIMENTAL
Intervention: Bisoprolol 1.25 mg daily, increased to a maximum of 10 mg per day
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2647
Study: 7844685

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 2110430

Group type: EXPERIMENTAL
Intervention: Insulin and hydroxychloroquine (n = 11)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Glibenclamide and hydroxychloroquine (n = 8)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Insulin and placebo (n = 11)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Glibenclamide and placebo (n = 8)
Number of subjects: 38
Study: 681529

Group type: EXPERIMENTAL
Intervention: Decision-making and self-management program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 31924567

Group type: EXPERIMENTAL
Intervention: Vaginal breech birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned caesarean birth
Number of subjects: 0
Study: 31542451

Group type: EXPERIMENTAL
Intervention: Room air inhalation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Saline inhalation
Number of subjects: 30
Study: 27856801

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) 40 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methylprednisolone acetate (MA) 40 mg
Number of subjects: 40
Study: 25890808

Group type: EXPERIMENTAL
Intervention: Mobile-bearing TKA implant
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fixed-bearing TKA implant
Number of subjects: 61
Study: 23376864

Group type: EXPERIMENTAL
Intervention: Sildenafil, 50 to 100 mg as needed
Number of subjects: 102
Study: 21795740

Group type: EXPERIMENTAL
Intervention: Partially hydrogenated soybean oil (15.7 g/day IP‐TFA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control oil without IP‐TFA
Number of subjects: 52
Study: 19750794

Group type: EXPERIMENTAL
Intervention: Sit-stand workstation paradigm
Number of subjects: 60
Study: 18003511

Group type: EXPERIMENTAL
Intervention: 2 ng/ml effect compartment controlled remifentanil
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4 ng/ml effect compartment controlled remifentanil
Number of subjects: 45

Group type: COMPARATOR
Intervention: No remifentanil
Number of subjects: 45
Study: 15003429

Group type: EXPERIMENTAL
Intervention: Citalopram for up to 12 weeks
Number of subjects: 24
Study: 11465304

Group type: EXPERIMENTAL
Intervention: Tapered discontinuation of cyclosporin microemulsion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abrupt discontinuation of cyclosporin microemulsion
Number of subjects: 0
Study: 9479803

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1481786

Group type: EXPERIMENTAL
Intervention: Family Bereavement Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 4063085

Group type: EXPERIMENTAL
Intervention: Indoor therapy exercises with elements of games (B2 subgroup)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Indoor therapy exercises with 5.2 mg of nitrong 1 hour prior to PT (B3 subgroup)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Bicycle ergometry with stable load of 50% of individual exercise tolerance (B4 subgroup)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Bicycle ergometry with stable load of 75% of individual exercise tolerance (B5 subgroup)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Bicycle ergometry with gradually increased load (50-75-90% of individual exercise tolerance) (B6 subgroup)
Number of subjects: 180
Study: 31082285

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy (CBGT)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 108
Study: 29195836

Group type: EXPERIMENTAL
Intervention: Switch to monotherapy from two non‐clozapine oral antipsychotics
Number of subjects: 90

Group type: COMPARATOR
Intervention: Stay on polypharmacy with two non‐clozapine oral antipsychotics
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Switch to monotherapy from combinations involving clozapine or an injectable antipsychotic
Number of subjects: 90

Group type: COMPARATOR
Intervention: Stay on polypharmacy with combinations involving clozapine or an injectable antipsychotic
Number of subjects: 90
Study: 27339838

Group type: EXPERIMENTAL
Intervention: Absorb scaffold
Number of subjects: 445

Group type: COMPARATOR
Intervention: Xience stent
Number of subjects: 445
Study: 24752130

Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 244

Group type: COMPARATOR
Intervention: CKC
Number of subjects: 244
Study: 21725935

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.02%) applied on surgical flaps (group A)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group without mitomycin C application (group B)
Number of subjects: 88
Study: 19615296

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIPPV)
Number of subjects: 1069

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Standard oxygen therapy
Number of subjects: 1069

Group type: COMPARATOR
Intervention: Economic evaluation
Number of subjects: 1069
Study: 17627166

Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g (first-generation cephalosporin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefuroxime 750 mg (second-generation cephalosporin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftazidime 1 g (third-generation cephalosporin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15333087

Group type: EXPERIMENTAL
Intervention: Patient-activated transtelephonic event recorder for 30 days, mean of 642 +/- 195 days after ablation
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Patient-activated transtelephonic event recorder for 30 days
Number of subjects: 244
Study: 11575619

Group type: EXPERIMENTAL
Intervention: Positive Distortion (PD) group (n=76)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Negative Distortion (ND) group (n=79)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (n=37)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Cutoff scores suggested for classification accuracy
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Rare Virtues and Deviance
Number of subjects: 192
Study: 9696497

Group type: EXPERIMENTAL
Intervention: Balloon inflation technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balloon deflation technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Portal pressure measurement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Short-term TIPS occlusion
Number of subjects: 20
Study: 8998252

Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg, equivalent to 2 to 3 cups of coffee)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 32
Study: 2233278

Group type: EXPERIMENTAL
Intervention: 50 mg nandrolone decanoate as an intramuscular depot every third week for 1 year
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol plus 1 mg norethisterone acetate daily for 1 year
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo injections every third week for 1 year
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo tablets for 1 year
Number of subjects: 79
Study: 630919

Group type: EXPERIMENTAL
Intervention: Use of a polyester fiber sponge to remove scales from lesions on the left side
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (no sponge used)
Number of subjects: 20
Study: 31989150

Group type: EXPERIMENTAL
Intervention: French fries prepared from frozen par-fried potatoes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: French fries prepared from fresh potatoes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: French fries with different toasting colors
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: All samples that were golden and light-golden
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Educational initiatives for food operators
Number of subjects: 31
Study: 30859964

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (DTB) 12mg/day titrating up to 48mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (DTB)
Number of subjects: 0
Study: 28566529

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer during the lean season
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 322
Study: 25040690

Group type: EXPERIMENTAL
Intervention: Autologous fibroblast cell culture (AFCC) on a collagen scaffold under a coronally advanced flap (CAF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) with coronally advanced flap (CAF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both AFCC and CTG
Number of subjects: 18
Study: 23425163

Group type: EXPERIMENTAL
Intervention: Dabigatran (150 mg twice daily)
Number of subjects: 2866

Group type: COMPARATOR
Intervention: Warfarin (active control)
Number of subjects: 2866

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 2866
Study: 21443601

Group type: EXPERIMENTAL
Intervention: Alitretinoin 30 mg and ketoconazole 200 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Alitretinoin 30 mg and simvastatin 40 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Alitretinoin 30 mg and ciclosporin A 300 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Alitretinoin 30 mg
Number of subjects: 54
Study: 19347367

Group type: EXPERIMENTAL
Intervention: Zinc supplements (10 mg/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Zinc supplements (10 mg/day) in frequent relapsers
Number of subjects: 81
Study: 16762760

Group type: EXPERIMENTAL
Intervention: 3-dimensional midwall ejection fraction (3DEF(mw))
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: midwall fractional shortening (FS(mw))
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: mitral annular motion (MAM)
Number of subjects: 49

Group type: COMPARATOR
Intervention: endocardial ejection fraction (EF(endo))
Number of subjects: 49

Group type: COMPARATOR
Intervention: endocardial fractional shortening (FS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 3D endocardial ejection fraction (3D EF(endo))
Number of subjects: 49

Group type: COMPARATOR
Intervention: systolic tissue velocity
Number of subjects: 49
Study: 15504127

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg b.i.d. (single-day oral treatment)
Number of subjects: 52
Study: 11825311

Group type: EXPERIMENTAL
Intervention: Tolterodine (2 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tolterodine (4 mg ER capsule, once daily)
Number of subjects: 0
Study: 9419912

Group type: EXPERIMENTAL
Intervention: Kaleidoscope distraction intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study: 8310986

Group type: EXPERIMENTAL
Intervention: AHA-type diet (32/10:8:8) for 6 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Monoene-enriched diet (34/11:11:5) for 6 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: High-saturated diet (35/14:10:4) for 6 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Low-fat diet (30/12:8:3) for 6 months
Number of subjects: 160
Study: 3355578

Group type: EXPERIMENTAL
Intervention: 200 micrograms Se as sodium selenite
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 170 mg alpha‐tocopherol
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 31524734

Group type: EXPERIMENTAL
Intervention: Arthroscopic suture repair with additional pronator quadratus (PQ) advancement (46 patients)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Arthroscopic suture repair alone (34 patients)
Number of subjects: 80
Study: 28223015

Group type: EXPERIMENTAL
Intervention: Piezoelectric device
Number of subjects: 19

Group type: COMPARATOR
Intervention: Traditional rotary bur
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 25381995

Group type: EXPERIMENTAL
Intervention: Lycium barbarum polysaccharide (LBP) at 300 mg/day
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: LBP
Number of subjects: 67
Study: 23608698

Group type: EXPERIMENTAL
Intervention: Breakfast before exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fasting before exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast at rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fasting before rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast before rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast omission
Number of subjects: 12
Study: 21672223

Group type: EXPERIMENTAL
Intervention: Community-based cluster randomised controlled trials
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Simulation exercise
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cluster size and number of clusters
Number of subjects: 5
Study: 19568710

Group type: EXPERIMENTAL
Intervention: Danggui Buxue Decoction No.1 (DB1)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 82
Study: 16948779

Group type: EXPERIMENTAL
Intervention: Dietary supplementation containing melatonin, l‐tryptophan, vitamin B6, folic acid, vitamin B12, methionine and betaine for 40 days.
Number of subjects: 351

Group type: COMPARATOR
Intervention: 20 mg omeprazole for 40 days.
Number of subjects: 351